Physician profile
Charles Morelli
NPI 1992703847
$18,102.30
in general payments reported to CMS, 2019-2025
28 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 87% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,934 · 2020: $2,122 · 2021: $3,670 · 2022: $2,864 · 2023: $3,202 · 2024: $1,194 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,456 · Travel and Lodging: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,456.30 |
| Travel and Lodging | $1,055.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $3,774.93 | 2019-2022 | |
| Gotham Surgical Solutions & Devices, INC. | $2,630.54 | 2019-2021 | |
| Arthrex, INC. | $2,103.50 | 2019-2020 | |
| Treace Medical Concepts, INC. | $2,036.20 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $1,351.49 | 2020-2025 | Nuzyra |
| Smith+Nephew, INC. | $1,057.72 | 2019-2025 | Grafix Pl, Acticoat 4" X 4", Collagenase Santyl |
| Abbvie INC. | $625.89 | 2021-2024 | |
| Advanced Oxygen Therapy INC. | $593.74 | 2019-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Nevro Corp. | $511.51 | 2021-2023 | Senza |
| Kowa Pharmaceuticals America, INC. | $366.99 | 2023 | Seglentis |
| Kerecis Limited | $309.65 | 2021-2022 | |
| Horizon Therapeutics Plc | $284.84 | 2019-2021 | |
| Amgen INC. | $283.80 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $230.00 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $221.63 | 2020-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $200.00 | 2019 | |
| Ani Pharmaceuticals, INC. | $183.57 | 2024-2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $161.78 | 2023 | Intellis Adaptivestim |
| Next Science LLC | $144.94 | 2023 | Surgx, Blastx, Xperience |
| Polarityte, INC. | $141.84 | 2019 | |
| Zimmer Biomet Holdings, INC. | $140.28 | 2023 | Tapestry |
| Lifenet Health | $139.60 | 2025 | Theragenesis Wound Matrix |
| Stryker Corporation | $137.57 | 2019-2025 | Dart-Fire, Prostep Mica |
| Melinta Therapeutics, LLC | $137.04 | 2019 | |
| Abbott Laboratories | $125.00 | 2023 | Diamondback Peripheral |
| Bioventus LLC | $114.12 | 2023 | Theragenesis Bilayer Wound Matrix |
| Mallinckrodt Enterprises LLC | $80.48 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Morelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.